450 followers
RT @HatragyiSafarne: The need and benefit of immune monitoring to define patient and disease heterogeneity, mechanisms of therapeutic actio…
RT @HatragyiSafarne: The need and benefit of immune monitoring to define patient and disease heterogeneity, mechanisms of therapeutic actio…
RT @HatragyiSafarne: The need and benefit of immune monitoring to define patient and disease heterogeneity, mechanisms of therapeutic actio…
The need and benefit of immune monitoring to define patient and disease heterogeneity, mechanisms of therapeutic action and efficacy of intervention therapy for precision medicine in type 1 diabetes. 👇 https://t.co/PJjqZ0Yxh2